24 April 2025
Unilever Trading Statement – First Quarter 2025 Resilient performance, full year outlook reconfirmed (unaudited) First Quarter 2025 USG Turnover Vs 2024 Unilever 3.0% €14.8bn (0.9)%…
23 April 2025
B.P. Marsh & Partners Plc (“B.P. Marsh” or the “Company”) New Investment – iO Finance Partners Topco Limited (“iO Partners”) B.P. Marsh (AIM: BPM), the…
(the “Company” or Group”) AGM Trading Update Trading and FY outlook in line with expectations with the Group well placed to make further progress…
22 April 2025
Enhertu plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2-positive metastatic breast…
17 April 2025
B.P. Marsh & Partners Plc (“B.P. Marsh”, “the Company” or “the Group”) Special Dividend Declaration Further to the announcement made on 25 March 2024,…
M. P. EVANS GROUP PLC (“THE GROUP”)ACQUISITION OF ADDITIONAL 2,750 PLANTED HECTARES 16 April 2025 M.P. Evans Group PLC, a producer of sustainable Indonesian palm oil, is…
Legal Entity Identifier: 2138006N35XWGK2YUK38 Henderson International Income Trust plc (“HINT”) Combination with JPMorgan Global Growth & Income plc (“JGGI”) Introduction The Board of Henderson…
Arexvy recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices GSK plc…